Insider Trading Arrangements

3 Months Ended

Jun. 30, 2026

During the three months ended June 30, 2026, the following executive and director (as defined in Rule 16a-1(f)) modified a “Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K intending to satisfy the affirmative defense conditions of Rule 10b5-1(c):

Name and Title

Total Shares of Common Stock to be Sold

Duration(1)

Action Date

Expiration Date

Steven R. Beauchamp

Executive Chairman and Director

160,000(2)(3)

August 14, 2026 - January 31, 2027

May 15, 2026

January 31, 2027

(1) The Rule 10b5-1trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the expiration date listed in the table.

(2) Includes 100,000 shares held directly by Mr. Beauchamp and 60,000 shares to be sold by the IRIE Family Trust for the benefit of Mr. Beauchamp’s children and for which Mr. Beauchamp's spouse serves as the trustee.

(3) The number of shares that will be sold is determined, in part, based on pricing triggers outlined in the Rule 10b5-1 trading arrangement.

No directors or officers entered into or terminated a “non-Rule 10b5-1 trading arrangement” as defined in Item 408(a) of Regulation S-K during the three months ended June 30, 2026.

Non-Rule 10b5-1 Arrangement Adopted

false

Non-Rule 10b5-1 Arrangement Terminated

false

Steven R. Beauchamp [Member]

Trading Arrangements, by Individual

Name

Steven R. Beauchamp

Title

Executive Chairman and Director

Rule 10b5-1 Arrangement Adopted

true